Please wait
S-8 EX-FILING FEES 0001611747 Fees to be Paid N/A 0001611747 1 2025-11-11 2025-11-11 0001611747 2025-11-11 2025-11-11 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-8

Scinai Immunotherapeutics Ltd.

Table 1: Newly Registered Securities

                                       
Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                       
Equity   Ordinary Shares, no par value   (1)   Other   4,000,000,000   $ 0.0003   $ 1,200,000.00   0.0001381   $ 165.72
                                       
Total Offering Amounts:   $ 1,200,000.00         165.72
Total Fee Offsets:               0.00
Net Fee Due:             $ 165.72

 

__________________________________________
Offering Note(s)

(1) Deposited as American Depositary Shares (“ADSs”), evidenced by American Depositary Receipts, issuable upon deposit of the ordinary shares, no par value (“Ordinary Shares”), of Scinai Immunotherapeutics Ltd. (the “Company”) registered hereby are registered on a separate registration statement on Form F-6 (File No. 333-203333). Each ADS represents four thousand (4,000) Ordinary Shares.

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall also cover any additional Ordinary Shares that become issuable under the Company’s 2018 Share Option Plan, as amended by reason of any stock dividend, stock split, or other similar transaction.

Estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act and based on the average of the high and low prices of the Company's ADSs reported on the NASDAQ Capital Market on November 7, 2025, which date is within five business days of the filing of this Registration Statement on Form S-8.